The estimated Net Worth of Endurance (Cayman) Ltd Sb I... is at least $300 Million dollars as of 30 June 2023. Endurance I owns over 700 units of Vir Biotechnology Inc stock worth over $130,636,041 and over the last 5 years Endurance sold VIR stock worth over $169,600,272.
Endurance has made over 47 trades of the Vir Biotechnology Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Endurance sold 700 units of VIR stock worth $17,577 on 30 June 2023.
The largest trade Endurance's ever made was buying 950,000 units of Vir Biotechnology Inc stock on 16 October 2019 worth over $19,000,000. On average, Endurance trades about 146,439 units every 29 days since 2019. As of 30 June 2023 Endurance still owns at least 16,684,041 units of Vir Biotechnology Inc stock.
You can see the complete history of Endurance I stock trades at the bottom of the page.
Over the last 5 years, insiders at Vir Biotechnology Inc have traded over $197,171,926 worth of Vir Biotechnology Inc stock and bought 6,960,011 units worth $139,246,875 . The most active insiders traders include Norbert W Bischofberger, Endurance (Cayman) Ltd Sb I..., and Kristina Burow. On average, Vir Biotechnology Inc executives and independent directors trade stock every 7 days with the average trade being worth of $478,115. The most recent stock trade was executed by Janet Napolitano on 9 September 2024, trading 12,190 units of VIR stock currently worth $95,082.
vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Vir Biotechnology Inc executives and other stock owners filed with the SEC include: